Phase 2 Study of Androgen Deprivation Therapy (ADT) Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

Trial Profile

Phase 2 Study of Androgen Deprivation Therapy (ADT) Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 May 2016

At a glance

  • Drugs Degarelix (Primary) ; Doxorubicin; Estramustine; Ketoconazole
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Nov 2015 Planned End Date changed from 1 Oct 2023 to 1 Nov 2023 as reported by ClinicalTrials.gov.
    • 12 Nov 2015 Planned primary completion date changed from 1 Oct 2020 to 1 Nov 2020 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top